PROCEPT BioRobotics Quarterly Income Statements Chart
Quarterly
|
Annual
PROCEPT BioRobotics Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue | 79,182,000 | 69,162,000 | 68,236,000 | 58,370,000 | 53,353,000 | 44,539,000 | 43,581,000 | 35,102,000 | 33,104,000 | 24,404,000 | 23,777,000 | 20,349,000 | 16,691,000 | 14,197,000 | 10,138,000 | 8,668,000 |
| yoy | 48.41% | 55.28% | 56.57% | 66.29% | 61.17% | 82.51% | 83.29% | 72.50% | 98.33% | 71.90% | 134.53% | 134.76% | ||||
| qoq | 14.49% | 1.36% | 16.90% | 9.40% | 19.79% | 2.20% | 24.16% | 6.04% | 35.65% | 2.64% | 16.85% | 21.92% | 17.57% | 40.04% | 16.96% | |
| cost of sales | 27,436,000 | 25,001,000 | 24,564,000 | 21,459,000 | 21,871,000 | 19,505,000 | 22,326,000 | 16,228,000 | 14,675,000 | 11,913,000 | 13,101,000 | 10,118,000 | 8,205,000 | 6,505,000 | 5,622,000 | 4,428,000 |
| gross profit | 51,746,000 | 44,161,000 | 43,672,000 | 36,911,000 | 31,482,000 | 25,034,000 | 21,255,000 | 18,874,000 | 18,429,000 | 12,491,000 | 10,676,000 | 10,231,000 | 8,486,000 | 7,692,000 | 4,516,000 | 4,240,000 |
| yoy | 64.37% | 76.40% | 105.47% | 95.57% | 70.83% | 100.42% | 99.09% | 84.48% | 117.17% | 62.39% | 136.40% | 141.30% | ||||
| qoq | 17.18% | 1.12% | 18.32% | 17.24% | 25.76% | 17.78% | 12.62% | 2.41% | 47.54% | 17.00% | 4.35% | 20.56% | 10.32% | 70.33% | 6.51% | |
| gross margin % | 65.35% | 63.85% | 64.00% | 63.24% | 59.01% | 56.21% | 48.77% | 53.77% | 55.67% | 51.18% | 44.90% | 50.28% | 50.84% | 54.18% | 44.55% | 48.92% |
| operating expenses: | ||||||||||||||||
| research and development | 17,632,000 | 16,402,000 | 15,066,000 | 16,647,000 | 17,501,000 | 13,084,000 | 14,496,000 | 11,600,000 | 11,613,000 | 10,737,000 | 9,682,000 | 7,582,000 | 6,706,000 | 5,011,000 | 5,076,000 | 4,919,000 |
| selling, general and administrative | 56,303,000 | 55,197,000 | 48,316,000 | 42,691,000 | 40,809,000 | 39,599,000 | 36,316,000 | 32,883,000 | 32,441,000 | 30,131,000 | 26,034,000 | 24,754,000 | 19,655,000 | 18,385,000 | 16,271,000 | 12,118,000 |
| total operating expenses | 73,935,000 | 71,599,000 | 63,382,000 | 59,338,000 | 58,310,000 | 52,683,000 | 50,812,000 | 44,483,000 | 44,054,000 | 40,868,000 | 35,716,000 | 32,336,000 | 26,361,000 | 23,396,000 | 21,347,000 | 17,037,000 |
| income from operations | -22,189,000 | -27,438,000 | -19,710,000 | -22,427,000 | -26,828,000 | -27,649,000 | -29,557,000 | -25,609,000 | -25,625,000 | -28,377,000 | -25,040,000 | -22,105,000 | -17,875,000 | -15,704,000 | -16,831,000 | -12,797,000 |
| yoy | -17.29% | -0.76% | -33.32% | -12.43% | 4.69% | -2.57% | 18.04% | 15.85% | 43.36% | 80.70% | 48.77% | 72.74% | ||||
| qoq | -19.13% | 39.21% | -12.11% | -16.40% | -2.97% | -6.46% | 15.42% | -0.06% | -9.70% | 13.33% | 13.28% | 23.66% | 13.82% | -6.70% | 31.52% | |
| operating margin % | -28.02% | -39.67% | -28.89% | -38.42% | -50.28% | -62.08% | -67.82% | -72.96% | -77.41% | -116.28% | -105.31% | -108.63% | -107.09% | -110.61% | -166.02% | -147.63% |
| interest expense | -895,000 | -877,000 | -969,000 | -1,140,000 | -1,030,000 | -1,045,000 | -1,125,000 | -1,019,000 | -965,000 | -886,000 | -866,000 | -1,455,000 | -1,441,000 | -1,421,000 | -1,440,000 | -1,469,000 |
| interest and other income | 3,506,000 | 3,578,000 | 1,823,000 | 2,593,000 | 2,232,000 | 2,737,000 | 3,178,000 | 2,006,000 | 1,305,000 | 779,000 | 992,000 | 947,000 | 132,000 | -60,000 | -77,000 | 163,000 |
| net income | -19,578,000 | -24,737,000 | -18,856,000 | -20,974,000 | -25,626,000 | -25,957,000 | -27,504,000 | -24,622,000 | -25,285,000 | -28,484,000 | -28,172,000 | -22,613,000 | -19,184,000 | -17,185,000 | -18,348,000 | -14,103,000 |
| yoy | -23.60% | -4.70% | -31.44% | -14.82% | 1.35% | -8.87% | -2.37% | 8.88% | 31.80% | 65.75% | 53.54% | 60.34% | ||||
| qoq | -20.86% | 31.19% | -10.10% | -18.15% | -1.28% | -5.62% | 11.70% | -2.62% | -11.23% | 1.11% | 24.58% | 17.87% | 11.63% | -6.34% | 30.10% | |
| net income margin % | -24.73% | -35.77% | -27.63% | -35.93% | -48.03% | -58.28% | -63.11% | -70.14% | -76.38% | -116.72% | -118.48% | -111.13% | -114.94% | -121.05% | -180.98% | -162.70% |
| net income per share | -0.35 | -0.45 | -0.34 | -0.4 | -0.5 | -0.51 | -0.54 | -0.51 | -0.56 | -0.63 | -0.63 | -0.51 | -0.43 | -0.39 | 2.01 | -1.22 |
| weighted-average common shares used to | ||||||||||||||||
| compute net income per share attributable to | ||||||||||||||||
| common shareholders, basic and diluted | 55,445 | 54,917 | 575 | 52,011 | 51,622 | 51,011 | 1,124 | 48,310 | 45,160 | 45,066 | 124 | 44,640 | 44,324 | 43,855 | 9,119 | 11,580 |
| other comprehensive loss: | ||||||||||||||||
| foreign currency translation adjustment | -367 | 109 | ||||||||||||||
| unrealized gain on cash equivalents | -114 | 29 | -21 | 21 | -223 | 185 | 85 | 1 | -6.75 | -2 | ||||||
| comprehensive loss | -19,945 | -24,628 | -18,724 | -20,991 | -25,740 | -25,928 | -27,414 | -24,622 | -25,306 | -28,463 | -28,395 | -22,428 | -19,099 | -17,184 | -18,361 | -14,105 |
| other comprehensive gain: | ||||||||||||||||
| unrealized loss on cash equivalents | -25.5 | -17 |
We provide you with 20 years income statements for PROCEPT BioRobotics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PROCEPT BioRobotics stock. Explore the full financial landscape of PROCEPT BioRobotics stock with our expertly curated income statements.
The information provided in this report about PROCEPT BioRobotics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.